Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone after PCI compared with bare-metal stents and drug-eluting stents
2006-000770-75Phase 3Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Maggiore della Carità
- Start
- Apr 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of prednisone in coronary arteriosclerosis (3 arms), sponsored by Azienda Ospedaliero-Universitaria Maggiore della Carità. Primary endpoint: Major adverse cardiac events at 12 months. Started Apr 2006; status: completed.
02
Drugs
prednisone
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2006-000770-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000770-75.